Caravelle, SA

What Caravelle, SA does

Caravelle, SA (legal entity SAS CARAVELLE, RCS Paris 347 972 283) is a Paris-headquartered, family-owned diversified investment group founded in 1995 by Pierre-André Martel. The group invests its own equity — with no external LPs disclosed — as a long-term shareholder primarily in French small and medium enterprises with turnover between €50M and €300M, taking majority stakes in most cases and minority positions selectively. The group's stated thesis is to support the national and international development of portfolio companies in industry and services, with historical activity spanning pharmacy, industrial vehicles, mechanics, software, and hospitality.

Following an early phase focused on turnaround investments (1995–2007, later housed in Arcole Industries), Caravelle under Hélène Martel-Massignac (2012–2017) pivoted toward investing in in-bonis companies across industry, services, tourism, and hospitality. Since 2017, the group has been led by Lorène Martel (Présidente), with Charles Vilgrain serving as Managing Partner and a bench that includes Claire Benoist (CFO/Secrétaire Générale), Charles des Aulnois (Partner), Miloud Chahlafi (Operating Partner), and senior investment directors Thibaud Morin and Thomas de Metz.

The current active portfolio comprises three core positions: Mayoly (minority, a French pharmaceutical laboratory that became a European gastroenterology leader following its acquisition of Ipsen's Family Health division, with activities also in dermocosmetics and consumer healthcare, held since 2022); Visionix/Luneau Technology (majority, a leader in ophthalmic diagnostic and refractive measurement instruments, held since 2019); and Kestrel Vision (majority, a global machine vision platform for mandatory inspection in multi-material rigid packaging, initiated via the 2017 acquisition of Tiama). Caravelle has historically realized exits including Belambra (2014–2026), Naturex (2012–2018), Cooper (2000–2016), Benalu (2004–2016), Marrel (2004–2013), Sopra (2005–2013), Edbro (1998–2012), Fruehauf (2004–2007), XRT (2003–2007), and Sonovision (1998–2005). The consolidated group employs approximately 2,700 staff across its portfolio. As a private family holding, Caravelle generates returns through portfolio operating performance and divestments rather than fee-bearing fund management, with no publicly disclosed pricing or product distribution.

Name

Caravelle, SA

Legal name

SAS CARAVELLE

Website

https://caravelle.fr

Company type

Private

Founded year

1995

Operating status

Operating

Short description

Caravelle, SA is a Paris-based, family-owned investment group founded in 1995 that deploys its own equity as a long-term shareholder in French SMEs (€50M–€300M turnover), with active portfolio companies in pharmaceuticals (Mayoly), ophthalmic instruments (Visionix), and machine vision inspection (Kestrel Vision).

Ownership category

akta.pro rank

Product category

Private Equity Investment Holding

NAICS

All Other Financial Investment Activities (52399), Other Financial Investment Activities (5239)

SIC

Investors, Nec (6799)

akta.pro primary industry

Lower Middle-Market Business Brokerage (FSAEAIAB)

Keywords

• Private equity holdings
• Family-owned investment group
• SME equity investment
• Long-term equity participation
• Turnaround investments

Headquarters

HQ city

Paris

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Others

Revenue model

1. Portfolio Company Returns: Returns from majority-owned and minority investments in portfolio companies across pharmaceuticals, visual health, machine vision, hospitality, and industrial sectors.
2. Investment Management: Long-term equity investments in French SMEs with €50M to €300M turnover, generating returns through value creation and eventual divestment.

Go-to-market motion1 record

Marketing channels1 record

Core offering

Caravelle, SA is a family-owned diversified investment group that takes majority and minority equity stakes in French SMEs with turnover between €50M and €300M. The group invests its own funds as a long-term, agile partner, focusing on industry and services sectors and historically specializing in company turnarounds. It currently holds stakes in pharmaceutical, visual healthcare, and machine vision companies, with a consolidated headcount of approximately 2,700 across its portfolio.

Product overview

Caravelle, SA is a family-owned diversified investment group, not a product company. It operates as a holding company that makes majority and minority investments in French SMEs (€50M to €300M turnover) across industry and services sectors. The group's portfolio consists of controlled and minority-held companies including: Mayoly Spindler (pharmaceutical/gastroenterology), Visionix (ophthalmic diagnostic instruments), and Kestrel Vision (machine vision inspection systems). The investment strategy focuses on supporting national and international development of portfolio companies rather than developing a unified product platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Mayoly Spindler Family-owned and independent French pharmaceutical laboratory specializing in gastroenterology following the acquisition of Ipsen's Family Health division, with additional activities in dermocosmetics and consumer healthcare (CHC). Caravelle holds a minority non-listed stake.
• Visionix (Luneau Technology) Leader in visual healthcare that develops, manufactures, and commercializes ophthalmic diagnostic instruments and refractive measurement devices. Caravelle holds a majority non-listed stake.
• Kestrel Vision Global leader in machine vision inspection for multi-material rigid packaging, serving manufacturing and filling operations. Caravelle holds a majority non-listed stake.

Quantifiable outcome

• Successfully turnaround and rescale multiple companies across diverse sectors (pharmacy, industrial vehicles, mechanics, software, hospitality)

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

14 partnerships are on record, tiered core and minor.

• MayolycoreOthersPharmaceutical laboratory investment (since 2022). Family-owned and independent pharmaceutical company which, following the acquisition of Ipsen's Family Health division, forms a European leader in gastroenterology. Caravelle holds a minority non-listed stake.
• Visionix (Luneau Technology)coreOthersVisual healthcare company (since 2019). Leader in developing, manufacturing and selling ophthalmic diagnostic and refractive measurement instruments. Caravelle holds a majority non-listed stake.
• Kestrel VisioncoreOthersMachine vision company (since 2017), initiated with acquisition of Tiama. Global player in mandatory control and inspection for multi-material rigid packaging manufacturing and filling. Caravelle holds a majority non-listed stake.
• BelambraminorOthersHoliday clubs operator (2014-2026). Leader in holiday clubs in France. Caravelle held a majority non-listed stake before divestment.
• NaturexminorOthersPlant-based natural ingredients company (2012-2018). Global leader in specialty plant-based natural ingredients. Caravelle held a minority listed stake before divestment.
• CooperminorOthersOTC pharmaceutical laboratory (2000-2016). Leading French OTC laboratory. Caravelle held a majority non-listed stake before divestment.
• BenaluminorOthersAluminum tipper manufacturer (2004-2016). European leading producer of aluminium tippers for industrial vehicles. Caravelle held a majority non-listed stake before divestment.
• MarrelminorOthersHydraulic components manufacturer (2004-2013). French leading producer of hydraulic components and equipment for industrial vehicles. Caravelle held a majority non-listed stake before divestment.
• SopraminorOthersIT services and software company (2005-2013). Leading consulting, IT services and software development company. Caravelle held a minority listed stake before divestment.
• EdbrominorOthersHydraulic systems manufacturer (1998-2012). Leader in on-vehicle hydraulic systems. Caravelle held a majority non-listed stake before divestment.
• FruehaufminorOthersIndustrial trailers manufacturer (2004-2007). Design and manufacturing of industrial trailers. Caravelle held a majority non-listed stake before divestment.
• XRTminorOthersCash management software company (2003-2007). Design of cash management software. Caravelle held a minority listed stake before divestment.
• SonovisionminorOthersLogistics engineering company (1998-2005). European leader in logistics and document engineering. Caravelle held a majority non-listed stake before divestment.
• OVHminorOthersWeb hosting provider for the Caravelle corporate website. Located at 2 rue Kellermann, 59100 Roubaix, France.

Scale indicators3 records

Recent moves15 records

Expansion highlights4 records

Broad incumbents

• PAI Partners: Major European PE firm headquartered in Paris focused on mid- to large-cap companies. Overlaps with Caravelle's French SME focus and majority-equity investment approach, though at larger ticket sizes.
• Tikehau Capital: French alternative asset manager with private equity, real estate, and debt strategies. Comparable for French mid-market focus and long-term patient capital orientation.
• Eurazeo: One of Europe's largest listed private investment groups with deep French mid-market exposure. Comparable to Caravelle for its focus on majority stakes in French SMEs, though significantly larger and more diversified.
• Bpifrance Investissement: French sovereign-backed investor and fund-of-funds active across all stages of French SME financing. Overlaps with Caravelle's French SME focus but with much greater capital base and broader mandate.

Direct peers

• Arcole Industries: French family-backed turnaround specialist. Caravelle previously held a minority stake in Arcole until 2014, and the two share the same DNA of mid-market French SME turnarounds and long-hold family ownership.
• LBO France: Independent French PE firm investing in mid-cap companies across industries. Directly comparable investment sizing to Caravelle's €50M–€300M turnover target and French SME focus.
• Astorg: Independent European PE firm with strong French mid-market industrial and healthcare focus. Comparable deal sizing and sector mix (industrials, healthcare) to Caravelle's portfolio.
• Sagard: Canadian-rooted but strong French mid-market PE platform. Direct peer for mid-cap French SME buyouts with family-style long-term ownership approach.
• Weinberg Capital Partners: Independent French mid-market PE firm investing in SMEs/ETIs. Comparable transaction profile and sector appetite (industrials, healthcare, services) to Caravelle.
• Argos Wityu: Independent European mid-market PE firm with French headquarters. Comparable equity-ticket, sector mix, and long-hold partnership-style investing to Caravelle.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Subsidiaries3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caravelle, SA